Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H15NO |
Molecular Weight | 141.2108 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2CC[C@@H]1C[C@@H](O)C2
InChI
InChIKey=CYHOMWAPJJPNMW-RNLVFQAGSA-N
InChI=1S/C8H15NO/c1-9-6-2-3-7(9)5-8(10)4-6/h6-8,10H,2-5H2,1H3/t6-,7+,8-
Molecular Formula | C8H15NO |
Molecular Weight | 141.2108 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/10387002
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10387002
Pseudotropine (ψ-tropine, or psi-tropine) is an isomer of tropine. Pseudotropine is formed during NADPH-dependent reduction of the 3-carbonyl group of tropinone to a beta-hydroxyl group. Tropinone reductase-II is an enzyme responsible for this transformation. It is known, that tropinone reductase-II is also a key enzyme in the biosynthetic pathway of tropane alkaloids, which include medicinally important compounds such as hyoscyamine (atropine) and cocaine.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. | 1999 Aug 26 |
|
The new neuromuscular blocking agents: do they offer any advantages? | 2001 Dec |
|
Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action. | 2002 Apr |
|
Structure-activity relationships among derivatives of dicarboxylic acid esters of tropine. | 2002 Oct |
|
Calystegines in wild and cultivated Erythroxylum species. | 2005 Jun |
|
Quaternary derivatives of granatanol diesters: potent, ultrashort acting non-depolarizing neuromuscular relaxants. | 2006 Jul 4 |
|
The functional divergence of short-chain dehydrogenases involved in tropinone reduction. | 2008 May |
|
Treatment of Cushing disease: overview and recent findings. | 2010 Oct 21 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:58:30 GMT 2023
by
admin
on
Sat Dec 16 09:58:30 GMT 2023
|
Record UNII |
L9Q7Z9D09L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
205-226-5
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
DB04026
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
Pseudotropine
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
15742
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
135-97-7
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
DTXSID501026533
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
m9300
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
43871
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
57493
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY | |||
|
L9Q7Z9D09L
Created by
admin on Sat Dec 16 09:58:30 GMT 2023 , Edited by admin on Sat Dec 16 09:58:30 GMT 2023
|
PRIMARY |